Regulation 4 Placing a veterinary medicinal product on the marketE1

England, Wales and Scotland

F1(1)

No person may place a veterinary medicinal product on the market unless the Secretary of State has—

(a)

as regards a product to which Schedule 1B applies, issued a QNIG certificate in respect of that product;

(b)

otherwise, granted a marketing authorisation in respect of that product.

(2)

No person may certify data in relation to an application for a marketing authorisation or in relation to an existing marketing authorisation if they know that those data are false, or do not believe that they are accurate.

(3)

Schedule 1 (marketing authorisations) has effect.

F2(4)

Schedule 1A (converted EU marketing authorisations) has effect.

F3(5)

Schedule 1B (Northern Ireland qualifying good marketing authorisations) has effect.

Annotations

Textual amendments

F1: Reg. 4(1) substituted (E.W.S.) (31.12.2020) by The Veterinary Medicines and Animals and Animal Products (Examination of Residues and Maximum Residue Limits) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/676), regs. 1, 3(3) (as amended by S.I. 2020/1461, regs. 1(2)(a), 3(2)(b)(3)(a)); 2020 c. 1, Sch. 5 para. 1(1)
F2: Reg. 4(4) inserted (E.W.S.) (31.12.2020) by The Food and Drink, Veterinary Medicines and Residues (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/865), regs. 1(2), 17(2); 2020 c. 1, Sch. 5 para. 1(1)
F3: Reg. 4(5) inserted (E.W.S.) (31.12.2020) by The Veterinary Medicines and Residues (Amendment) (EU Exit) Regulations 2020 (S.I. 2020/1461), regs. 1(2)(b), 4(2)

Extent

E1: This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only